Draft Guidelines - Surveillance and Response to Carbapenemase-Producing Enterobacterales (CPE) in NSW Health Facilities

Surveillance and Response to Carbapenemase-Producing Enterobacterales (CPE) in NSW Health Facilities (GL2019_012) has been reviewed and revised.

Please click the links below to read the draft revised Guideline (comprising guideline summary and guideline sections) and provide comments in the relevant sections of the feedback form.

The closing date for comments is 5:00 pm Monday 22 July 2024.

Should you have any enquiries please email CEC-HAI@health.nsw.gov.au

Draft guidelines

Personal details

Name *

Position *

Organisation *

Email address *

Feedback Guideline Summary

Guideline Summary

Key Principles

Feedback Guideline

1 - Background

1.1 - About this document

1.2 - Key definitions

2 - Public Health Significance

3 - Governance

3.1 - Roles and responsibilities

4 - Screening, detection and investigation of CPE

4.1 - Screening

4.2 - Actions if one case of CPE is identified

4.3 - Local transmission (or if more than one case is identified)

4.4 - Environmental screening

4.5 - Laboratory testing

4.6 - Antimicrobial Stewardship

Draft Guidelines - Surveillance and Response to Carbapenemase-Producing Enterobacterales (CPE) in NSW Health Facilities

Personal details

Feedback Guideline Summary

Feedback Guideline

1 - Background

2 - Public Health Significance

3 - Governance

4 - Screening, detection and investigation of CPE

5 - References

6.1 - Appendix 1: Infection prevention and control measures for CPE case management

6.2 - Appendix 2: Implementation checklist for CPE

Other/additional comment